Publicaties

Coenen NCB, Dijkstra BAG, Batalla A, Schellekens AFA.  2019.  Detoxification of a Patient With Comorbid Dependence on Phenibut and Benzodiazepines by Tapering With Baclofen: Case Report. J Clin Psychopharmacol. 39(5):511-514.

Chye Y, Solowij N, Ganella EP, Suo C, Yücel M, Batalla A, Cousijn J, Goudriaan AE, Martin-Santos R, Whittle S et al..  2017.  Role of orbitofrontal sulcogyral pattern on lifetime cannabis use and depressive symptoms.. Prog Neuropsychopharmacol Biol Psychiatry. 79(Pt B):392-400.

Chye Y, Solowij N, Suo C, Batalla A, Cousijn J, Goudriaan AE, Martin-Santos R, Whittle S, Lorenzetti V, Yücel M.  2017.  Orbitofrontal and caudate volumes in cannabis users: a multi-site mega-analysis comparing dependent versus non-dependent users.. Psychopharmacology (Berl).

Carpentier PJ, Van Gogh MT, Knapen LJM, Buitelaar JK, DeJong CA.  2011.  Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients.. Eur Addict Res. 17(1):10-20.

Carpentier PJ, Knapen LJM, Van Gogh MT, Buitelaar JK, DeJong CA.  2012.  Addiction in developmental perspective: influence of conduct disorder severity, subtype, and attention-deficit hyperactivity disorder on problem severity and comorbidity in adults with opioid dependence.. J Addict Dis. 31(1):45-59.

Carpentier PJ, DeJong CA, Dijkstra BAG, Verbrugge C, Krabbe PFM.  2005.  A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Addiction. 100

Carpentier PJ, Arias Vasquez A, Hoogman M, Onnink M, Kan CC, Kooij JJS, Makkinje R, Iskandar S, Kiemeney LA, DeJong CA et al..  2012.  Shared and unique genetic contributions to attention deficit/hyperactivity disorder and substance use disorders: A pilot study of six candidate genes.. Eur Neuropsychopharmacol.

Carpentier PJ.  2012.  Addiction and the role of childhood externalising disorders. Sociale Wetenschappen. Ph. D.:182.

Carpentier PJ, Krabbe PFM, Van Gogh MT, Knapen LJM, Buitelaar JK, DeJong CA.  2009.  Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. American Journal of Addiction. 6(18):80.

Carpentier PJ, Van Gogh MT, Knapen LJM, Buitelaar JK.  2011.  Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients.. Eur Addict Res. 17(1):10-20.